AB SCIENCE |
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.92 EUR | -0.83% |
|
-3.90% | -45.99% |
| 04-04 | AB Science's Reconsideration Request for ALS Treatment Granted Eligibility in Canada | MT |
| 04-03 | AB Science: reconsideration possible for masitinib in ALS | CF |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 2.240 | 2.605 | 3.130 |
| Spread/Res. | -14.29% | -26.30% | -38.66% |
| Spread/Supp. | +1.91% | +1.91% | +10.98% |
| Support | 1.884 | 1.884 | 1.730 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- AB Stock
- Charts AB Science
